Palisade Bio receives milestone payment for PALI-2108 development
Palisade Bio has received a milestone payment from the US Crohn's and Colitis Foundation for the development of its lead programme, PALI-2108.
Giiant Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Giiant Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Giiant Pharma Today - Breaking & Trending Today
Palisade Bio Reports Third Quarter 2023 Financial Results
– Transformational transaction jumpstarts development pipeline into high-value inflammatory bowel disease (IBD) market – Lead program, PALI-2108, oral...
Source: globenewswire.com
Five biotech companies in Montreal to keep an eye on
Discover five of the hottest biotech companies in Montreal, that were founded over the past decade and have received funding in recent times.
Source: labiotech.eu
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers American Rebel Holdings, Inc. (NASDAQ:AREB) rose 39.7% to $1.25 in pre-market trading. American Rebel announced Wednesday, that its safe...
Source: businessinsider.com
Palisade Bio's stock more than doubles on news of licensing deal with Giiant Pharma for IBD therapies
Palisade Bio Inc.’s stock more than doubled in price on Wednesday, after the company announced a licensing agreement with privately held Giiant Pharma Inc....
Source: marketwatch.com